SEC Form 4 · accession 0001104659-15-053992

SUNESIS PHARMACEUTICALS INC · SNSS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, CFO & Corp. Secretary

Period of report

Jul 24, 2015

Accepted (ET)

Jul 28, 2015 · 9:52 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001061027

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jul 24, 2015	X	11,105	$1.32	A	84,634	I	See footnote
Common Stock^F1	Jul 24, 2015	S	4,239	$3.4585	D	80,395	I	See footnote
Common Stock^F1	Jul 24, 2015	X	5,551	$1.32	A	85,946	I	See footnote
Common Stock^F1	Jul 24, 2015	S	2,119	$3.4585	D	83,827	I	See footnote
Common Stock	holding	—	—		—	49,913	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant (right to buy)^F1	$1.32	Jul 24, 2015	X	11,105	D	Apr 3, 2009	Apr 3, 2016	Common Stock	11,105	0	I
Warrant (right to buy)^F1	$1.32	Jul 24, 2015	X	5,551	D	Oct 30, 2009	Oct 30, 2016	Common Stock	5,551	0	I

F1The shares are held by the Bjerkholt/Hahn Family Trust for which reporting person is the Trustee.
F2On July 24, 2015, the reporting person exercised a warrant to purchase 11,105 shares of SNSS common stock for $1.32 a share. The reporting person paid the exercise price on a cashless basis, resulting in SNSS's withholding of 4,239 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 6,866 shares.
F3On July 24, 2015, the reporting person exercised a warrant to purchase 5,551 shares of SNSS common stock for $1.32 a share. The reporting person paid the exercise price on a cashless basis, resulting in SNSS's withholding of 2,119 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 3,432 shares.